MSH|^~\&|IGENE|MFT|EPIC|MFT|20251014155942||ORU^R01|ORIE-251014-9|T|2.3PID||9737383346|MR~B67890^^^RBS^MR||HAWES^Ygritte||20230209|F|||^^^^DL8 3QNORC|RE|LRI-5280001671|||||||||||||||||||^^^^^RBS^^^ODSOBR|1|Acme23469|Gen825750-LRI4|R59.3^Epilepsy - early onset or syndromic (402)^England-GenomicTestDirectory|R|201608030830|201608091650|OBX|1|TX|53577-3^Reason for study^LN|1|Patient may have infantile epilepsy.|OBX|2|CWE|51967-8^Genetic disease(s) assessed^LN|1.a|C0268126^Adenylosuccinate lyase deficiency^MedGen-Dis|OBX|3|CWE|51967-8^Genetic disease(s) assessed^LN|1.b|C0162635^Angelman syndrome^MedGen-Dis|OBX|4|CWE|51967-8^Genetic disease(s) assessed^LN|1.c|C2748910^Atypical Rett syndrome^MedGen-Dis|OBX|5|CNE|48018-6^Gene studied^LN|1.a|291^ADSL^HGNC-Symb|OBX|6|CNE|48018-6^Gene studied^LN|1.b|877^ALDH7A1^HGNC-Symb|OBX|7|CNE|48018-6^Gene studied^LN|1.c|30881^ALG13^HGNC-Symb|OBX|8|CNE|48018-6^Gene studied^LN|1.d|14561^ARHGEF9^HGNC-Symb|OBX|9|CNE|48018-6^Gene studied^LN|1.e|18060^ARX^HGNC-Symb|OBX|10|CNE|51968-6^Discrete variation analysis overall interpretation^LN|1|LA6576-8^Positive^LN|OBX|11|CWE|83006-7^Deletion-duplication overall interpretation^LN|1|LA26803-9^No deletion duplications detected in studied regions^LN|OBX|12|FT|51969-4^Full narrative report^LN|1|Result- Heterozygous for a single PNKP mutation; Heterozygous for a single PRRT2 mutation. No other reportable variants detected by sequencing and deletion/duplication analysis of the 75 genes included on this panel. \.br\\.br\ Interpretation: This individual is heterozygous for a novel disease-causing mutation in the PNKP gene. This gene is associated with an autosomal recessive disorder. A second mutation may exist that is undetectable by this test or this patient may incidentally be a heterozygous carrier of the PNKP mutation. The finding of a single mutation in PNKP is not sufficient to establish a diagnosis in this patient. This individual is heterozygous for a published missense variant in the PRRT2 gene. This gene is associated with autosomal dominant disorder. With the clinical and molecular information available at this time, the clinical significance of this variant is unknown. \.br\\.br\ Method – Using genomic DNA from the submitted specimen, the coding regions and splice junctions of 51 genes (all genes listed above except for CHRNA7 and MAGI2, since only large deletions have been reported in these genes) were sequenced with pair-end reads. Capillary sequencing was used to confirm all potentially pathogenic variants. Concurrent deletion/duplication testing was performed for the genes in the panel using exon-level oligo array CGH, except for FOXG1. Confirmation of copy number changes was performed by MLPA, qPCR, or repeat array CGH analysis. \.br\\.br\ Additional Information – The test also found likely benign variants in genes KANSL1 and PNKP.|OBX|13|TX|81293-3^Description of ranges of DNA sequences examined^LN|1|The sequencing component of the test includes all genes listed above except for CHRNA7 and MAGI2, since only large deletions have been reported in these genes.|OBX|14|CWE|62374-4^Human reference sequence assembly^LN|1|LA14029-5^GRCh37^LN|OBX|15|NM|82115-7^dbSNP version^LN|1|147|Attributes of First Discrete Genetic Variants: Report Section 2OBX|16|CNE|83005-9^Variant Category^LN|2a|LA26801-3^SimpleVariant^LN|OBX|17|CNE|81252-9^Discrete genetic variant^LN|2a|No Variant ID^NM_007254.3(PNKP):c.1315C>T(p.Arg439Ter)^ClinVar-V|OBX|18|CWE|48018-6^Gene studied^LN|2a|9154^PNKP^HGNC-Symb|OBX|19|CWE|51958-7^Transcript RefSeq ID^LN|2a|NM_007254.3^NM_007254.3^RefSeq-T|OBX|20|CWE|41103-3^Transcript DNA Change (cHGVS)^LN|2a|c.610C>T^c.1315C>T^HGVS.c|OBX|21|CWE|48005-3^Amino acid change p.HGVS^LN|2a|p.Arg204Ter^p.Arg439Ter^HGVS.p|OBX|22|CWE|48019-4^DNA change type^LN|2a|LA6690-7^Substitution^LN|OBX|23|CWE|48006-1^Amino acid change type^LN|2a|LA6699-8^Nonsense^LN|OBX|24|CWE|81290-9^Genomic DNA change (gHGVS)^LN|2a|NC_000019.9^NC_000019.9^RefSeq-G|OBX|25|ST|69547-8^Genomic ref allele^LN|2a|G|OBX|26|NR|81254-5^Genomic allele start-end^LN|2a|50367462^50367462|OBX|27|ST|69551-0^Genomic alt allele^LN|2a|A|OBX|28|CNE|81255-2^dbSNP ID^LN|2a|rs796052850^rs796052850^dbSNP|OBX|29|CWE|48001-2^Cytogenetic (chromosome) location^LN|2a|19q13.33^19q13.33^Chrom-Loc|OBX|30|CNE|48002-0^Genomic source class^LN|2a|LA6683-2^Germline^LN|OBX|31|CNE|53037-8^Genetic variation clinical significance^LN|2a|LA6668-3^Pathogenic^LN|OBX|32|CNE|69548-6^Genomic variant assessment^LN|2a|LA9633-4^Present^LN|OBX|33|CWE|81259-4^Probable associated phenotype^LN|2a|CN218420^Developmental delay AND/OR other significant developmental or morphological phenotypes^MedGen-Dis|OBX|34|CNE|53034-5^Allelic state^LN|2a|LA6706-1^Heterozygous^LN|OBX|35|CNE|83005-9^Variant Category^LN|2a|LA26801-3^Simple Variant^LN|OBX|36|CNE|81252-9^Discrete genetic variant^LN|2b|130039^NM_145239.2(PRRT2):c.67G>A(p.Glu23Lys)^ClinVar-V|OBX|37|CWE|48018-6^Gene studied^LN|2b|30500^PRRT2^HGNC-Symb|OBX|38|CWE|51958-7^Transcript RefSeq ID^LN|2b|NM_145239.2^NM_145239.2^RefSeq-T|OBX|39|CWE|41103-3^Transcript DNA Change (cHGVS)^LN|2b|c.67G>A^c.67G>A^HGVS.c|OBX|40|CWE|48005-3^Amino acid change p.HGVS^LN|2b|p.Glu23Lys^p.Glu23Lys^HGVS.p|OBX|41|CWE|48019-4^DNA change type^LN|2b|LA6690-7^Substitution^LN|OBX|42|CWE|81290-9^Genomic DNA change (gHGVS)^LN|2b|NC_000016.9^NC_000016.9^RefSeq-G|OBX|43|ST|69547-8^Genomic ref allele^LN|2b|G|OBX|44|NR|81254-5^Genomic allele location^LN|2b|29824442^29824442|OBX|45|ST|69551-0^Genomic alt allele^LN|2b|A|OBX|46|CNE|81255-2^dbSNP ID^LN|2b|rs140383655^rs140383655^dbSNP|OBX|47|CWE|48001-2^Cytogenetic (chromosome) location^LN|2b|16p11.2^16p11.2^Chrom-Loc|OBX|48|CNE|48002-0^Genomic source class^LN|2b|LA6683-2^Germline^LN|OBX|49|CNE|53037-8^Genetic variation clinical significance^LN|2b|LA6671-7^Uncertain Significance^LN|OBX|50|CNE|69548-6^Genomic variant assessment^LN|2b|LA9633-4^Present^LN|OBX|51|CWE|81259-4^Probable associated phenotype^LN|2b|C1510586^Autism spectrum disorders^MedGen-Dis|OBX|52|CNE|53034-5^Allelic state^LN|2b|LA6706-1^Heterozygous^LN|OBX|53|CNE|83005-9^Variant Category^LN|2c|LA26801-3^Simple Variant^LN|OBX|54|CNE|81252-9^Discrete genetic variant^LN|2c|205776^NM_001193466.1(KANSL1):c.727C>A(p.Gln243Lys)^ClinVar-V|OBX|55|CWE|48018-6^Gene studied^LN|2c|24565^KANSL1^HGNC-Symb|OBX|56|CWE|51958-7^Transcript RefSeq ID^LN|2c|NM_001193466.1^NM_001193466.1^RefSeq-T|OBX|57|CWE|41103-3^Transcript DNA Change(cHGVS)^LN|2c|c.727C>A^c.727C>A^HGVS.c|OBX|58|CWE|48005-3^Amino acid change p.HGVS^LN|2c|p.Gln243Lys^p.Gln243Lys^HGVS.p|OBX|59|CWE|48019-4^DNA change type^LN|2c|LA6690-7^Substitution^LN|OBX|60|CWE|48006-1^Amino acid change type^LN|2c|LA6698-0^Missense^LN|OBX|61|CWE|81290-9^Genomic DNA change (gHGVS)^LN|2c|NC_000017.10^NC_000017.10^RefSeq-G|OBX|62|ST|69547-8^Genomic ref allele^LN|2c|G|OBX|63|NR|81254-5^Genomic allele location^LN|2c|44248783^44248783|OBX|64|ST|69551-0^Genomic alt allele^LN|2c|T|OBX|65|CNE|81255-2^dbSNP ID^LN|2c|rs142096969^rs142096969^dbSNP|OBX|66|CWE|48001-2^Cytogenetic (chromosome) location^LN|2c|17q21.31^17q21.31^Chrom-Loc|OBX|67|CNE|48002-0^Genomic source class^LN|2c|LA6683-2^Germline^LN|OBX|68|CNE|53037-8^Genetic variation clinical significance^LN|2c|LA6674-1^Likely Benign^LN|OBX|69|CNE|69548-6^Genomic variant assessment^LN|2c|LA9633-4^Present^LN|OBX|70|CNE|53034-5^Allelic state^LN|2c|LA6706-1^Heterozygous^LN|OBX|71|CNE|83005-9^Variant Category^LN|2d|LA26801-3^Simple Variant^LN|OBX|72|CNE|81252-9^Discrete genetic variant^LN|2d|159792^NM_007254.3(PNKP):c.188C>T(p.Ala63Val)^ClinVar-V|OBX|73|CWE|48018-6^Gene studied^LN|2d|9154^PNKP^HGNC-Symb|OBX|74|CWE|51958-7^Transcript RefSeq ID^LN|2d|NM_007254.3^NM_007254.3^RefSeq-T|OBX|75|CWE|41103-3^Transcript DNA Change (cHGVS)^LN|2d|c.188C>T^c.188C>T^HGVS.c|OBX|76|CWE|48005-3^Amino acid change p.HGVS^LN|2d|p.Ala63Val^p.Ala63Val^HGVS.p|OBX|77|CWE|48019-4^DNA change type^LN|2d|LA6690-7^Substitution^LN|OBX|78|CWE|48006-1^Amino acid change type^LN|2d|LA6698-0^Missense^LN|OBX|79|CWE|81290-9^Genomic DNA change (gHGVS)^LN|2d|NC_000019.9^NC_000019.9^RefSeq-G|OBX|80|ST|69547-8^Genomic ref allele^LN|2d|G|OBX|81|NR|81254-5^Genomic allele location^LN|2d|50369666^50369666|OBX|82|ST|69551-0^Genomic alt allele^LN|2d|A|OBX|83|CNE|81255-2^dbSNP ID^LN|2d|rs3739173^rs3739173^dbSNP|OBX|84|CWE|48001-2^Cytogenetic (chromosome) location^LN|2d|19q13.33^19q13.33^Chrom-Loc|OBX|85|CNE|48002-0^Genomic source class^LN|2d|LA6683-2^Germline^LN|OBX|86|CNE|53037-8^Genetic variation clinical significance^LN|2d|LA6671-7^Uncertain Significance^LN|OBX|87|CNE|69548-6^Genomic variant assessment^LN|2d|LA9633-4^Present^LN|OBX|88|CWE|81259-4^Probable associated phenotype^LN|2d|C3150667^Early infantile epileptic encephalopathy 10^MedGen-Dis|OBX|89|CNE|53034-5^Allelic state^LN|2d|LA6706-1^Heterozygous^LN|